Copertina

Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Jindong Xie, Manqing Liu, Xinpei Deng, Yuhui Tang, Shaoquan Zheng, Xueqi Ou, Hailin Tang, Xiaoming Xie, Minqing Wu, Yutian Zou
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	iMeta
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Gut microbiota and tuberculosis
di: Yanhua Liu, et al.
Pubblicazione: (2025)

Cardiovascular disease therapeutics via engineered oral microbiota: Applications and perspective
di: Wenyu Zhen, et al.
Pubblicazione: (2024)

Neoadjuvant immunotherapy driven bladder preservation for muscle invasive bladder cancer
di: Jiao Hu, et al.
Pubblicazione: (2025)

iMLGAM: Integrated Machine Learning and Genetic Algorithm‐driven Multiomics analysis for pan‐cancer immunotherapy response prediction
di: Bicheng Ye, et al.
Pubblicazione: (2025)

The microbiome in cancer
di: Anqi Lin, et al.
Pubblicazione: (2025)

LTBR acts as a novel immune checkpoint of tumor‐associated macrophages for cancer immunotherapy
di: Liang Wang, et al.
Pubblicazione: (2024)

Cultivar‐specific preference of bacterial communities and host immune receptor kinase modulate the outcomes of rice–microbiota interactions
di: Jiwei Xu, et al.
Pubblicazione: (2025)

The challenge and opportunity of gut microbiota‐targeted nanomedicine for colorectal cancer therapy
di: Yaohua Wei, et al.
Pubblicazione: (2024)

Gut microbiota‐derived tryptophan metabolites improve total parenteral nutrition‐associated infections by regulating Group 3 innate lymphoid cells
di: Longchang Huang, et al.
Pubblicazione: (2025)

Efficacy and biomarker analysis of neoadjuvant disitamab vedotin (RC48‐ADC) combined immunotherapy in patients with muscle‐invasive bladder cancer: A multi‐center real‐world study
di: Jiao Hu, et al.
Pubblicazione: (2025)

Targeting DGKα/PA axis inhibits tumor immune evasion and augments sensitivity to immunotherapy in gastrointestinal cancers
di: Jie Chen, et al.
Pubblicazione: (2026)

Genome‐wide CRISPR screen reveals an uncharacterized spliceosome regulator as new candidate immunotherapy target
di: Tong Shao, et al.
Pubblicazione: (2025)

Gut microbial‐derived 3,4‐dihydroxyphenylacetic acid ameliorates reproductive phenotype of polycystic ovary syndrome
di: Pan Li, et al.
Pubblicazione: (2025)

RRM2‐targeted nanocarrier enhances radiofrequency ablation efficacy in hepatocellular carcinoma through ferroptosis amplification and immune remodeling
di: Weiliang Hou, et al.
Pubblicazione: (2025)

Spaceflight redefines ageing‐associated microbiota
di: Yuan Sun, et al.
Pubblicazione: (2025)

The impact of school heavy metal exposure on children's gut microbiota: The mediating role of environmental microorganisms
di: Yuchen Zou, et al.
Pubblicazione: (2025)

GutUDB: A comprehensive multiomics database for intestinal diseases
di: Yi Bao, et al.
Pubblicazione: (2024)

A new evaluation system for drug–microbiota interactions
di: Tian‐Hao Liu, et al.
Pubblicazione: (2024)

Understanding host immune responses in Clostridioides difficile infection: Implications for pathogenesis and immunotherapy
di: Lamei Wang, et al.
Pubblicazione: (2024)

tigeR: Tumor immunotherapy gene expression data analysis R package
di: Yihao Chen, et al.
Pubblicazione: (2024)

Single‐cell spatial transcriptomics reveals potential molecular mechanisms of Abelmoschus manihot (L.) medic in treating diabetic kidney disease
di: Chenhua Wu, et al.
Pubblicazione: (2025)

Vaginal microbiota are associated with in vitro fertilization during female infertility
di: Tao Wang, et al.
Pubblicazione: (2024)

Leveraging core enzyme structures for microbiota targeted functional regulation: Urease as an example
di: Shengguo Zhao, et al.
Pubblicazione: (2025)

Targeting SLC7A11 /xCT improves radiofrequency ablation efficacy of HCC by dendritic cells mediated anti‐tumor immune response
di: Yuzhao Jin, et al.
Pubblicazione: (2024)

Deciphering unique and shared interactions between the human gut microbiota and oral antidiabetic drugs
di: Huahui Ren, et al.
Pubblicazione: (2024)

Daily occupational exposure in swine farm alters human skin microbiota and antibiotic resistome
di: Dong‐Rui Chen, et al.
Pubblicazione: (2024)

Intestinal microbiota by angiotensin receptor blocker therapy exerts protective effects against hypertensive damages
di: Jing Li, et al.
Pubblicazione: (2024)

Maternal gut microbiota‐derived daidzein prevents osteoporosis in female offspring following prenatal prednisone exposure
di: Chi Ma, et al.
Pubblicazione: (2025)

RepliChrom: Interpretable machine learning predicts cancer‐associated enhancer‐promoter interactions using DNA replication timing
di: Fuying Dao, et al.
Pubblicazione: (2025)

Arbuscular mycorrhizal fungal interactions bridge the support of root‐associated microbiota for slope multifunctionality in an erosion‐prone ecosystem
di: Tianyi Qiu, et al.
Pubblicazione: (2024)

Inhibition of ferroptosis by microbiota‐derived lithocholic acid underlies the intestinal radioprotection of a host defensin‐derived oligopeptide
di: Xue Ouyang, et al.
Pubblicazione: (2026)

Nano‐plastics disrupt systemic metabolism by remodeling the bile acid–microbiota axis and driving hepatic–intestinal dysfunction
di: Yi Zhang, et al.
Pubblicazione: (2025)

Efficient and easy‐to‐use capturing three‐dimensional metagenome interactions with GutHi‐C
di: Yu‐Xi Lu, et al.
Pubblicazione: (2024)

Gut microbiome and metabolome characteristics of patients with cholesterol gallstones suggest the preventive potential of prebiotics
di: Ye Liu, et al.
Pubblicazione: (2025)

Hypertriglyceridemia‐modulated gut microbiota promotes lysophosphatidylcholine generation to aggravate acute pancreatitis in a TLR4‐dependent manner
di: Xiaofan Song, et al.
Pubblicazione: (2025)

Black rice diet alleviates colorectal cancer development through modulating tryptophan metabolism and activating AHR pathway
di: Ling Wang, et al.
Pubblicazione: (2024)

A gut microbiota‐bile acid axis inhibits the infection of an emerging coronavirus by targeting its cellular receptor aminopeptidase N
di: Ya‐Qing Zhang, et al.
Pubblicazione: (2025)

HLF and PPARα axis regulates metabolic‐associated fatty liver disease through extracellular vesicles derived from the intestinal microbiota
di: Xingzhen Yang, et al.
Pubblicazione: (2025)

The gut microbiota‐aromatic hydrocarbon receptor (AhR) axis mediates the anticolitic effect of polyphenol‐rich extracts from Sanghuangporus
di: Shi Zhong, et al.
Pubblicazione: (2024)

Navigating the future of nano‐pesticides: A perspective on design, efficacy, mechanisms, and environmental stewardship
di: Xile Deng, et al.
Pubblicazione: (2026)